Albumin-Biopharma correspond with the European Pharmacopoeia regulations for the finished product and raw materials Conditions in which albumin is indicated: shock (hemorrhagic, traumatic, thermal); acute hemorrhage; purulent-septic conditions; liver diseases with violation of albumin-synthesizing function; kidney diseases (nephritis, nephrotic syndrome); the burn disease; surgeries with using of artificial circulation; therapeutic plasmapheresis; hemolytic disease of newborns (HDN); preoperative hemodilution; cerebral edema; gastrointestinal disorders with impaired function of intestinal absorption or intestinal permeability.
Inbox, call or WhatsApp for more professional details. You can as well drop your contact in our inbox